| Literature DB >> 31753107 |
Laura M Enomoto1, Edward A Levine2, Perry Shen2, Konstantinos I Votanopoulos2.
Abstract
Complete surgical resection of metastatic melanoma has a known survival benefit. Treatment of metastatic melanoma, however, has become increasingly complex with the introduction of targeted treatments and immune checkpoint inhibitors. Integration of systemic medical therapy and surgical resection has shown promising results, with significantly improved long-term survivals. Results from current clinical trials are awaited to help further delineate the sequence and combination of systemic therapy and surgery.Entities:
Keywords: Metastasectomy; Metastatic melanoma; Oligometastatic melanoma; Stage IV melanoma
Mesh:
Year: 2019 PMID: 31753107 DOI: 10.1016/j.suc.2019.09.011
Source DB: PubMed Journal: Surg Clin North Am ISSN: 0039-6109 Impact factor: 2.741